225 related articles for article (PubMed ID: 21633361)
1. Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.
Xie CC; Lu L; Sun J; Zheng SL; Isaacs WB; Gronberg H; Xu J
J Hum Genet; 2011 Jul; 56(7):496-502. PubMed ID: 21633361
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study.
Cheng Y; Liu W; Kim ST; Sun J; Lu L; Sun J; Zheng SL; Isaacs WB; Xu J
Cancer Genet; 2011 Jul; 204(7):375-81. PubMed ID: 21872824
[TBL] [Abstract][Full Text] [Related]
4. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Zheng SL; Mychaleckyj JC; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Chang BL; von Kap-Herr C; Carpten JD; Pettenati M; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Mutat Res; 2003 Jul; 528(1-2):45-53. PubMed ID: 12873722
[TBL] [Abstract][Full Text] [Related]
6. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
7. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.
Jin G; Sun J; Liu W; Zhang Z; Chu LW; Kim ST; Sun J; Feng J; Duggan D; Carpten JD; Wiklund F; Grönberg H; Isaacs WB; Zheng SL; Xu J
Carcinogenesis; 2011 Jul; 32(7):1057-62. PubMed ID: 21551127
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
11. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jin G; Lu L; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Cannon-Albright LA; Camp NJ; Teerlink CC; Fitzgerald LM; Stanford JL; Wiley KE; Isaacs SD; Walsh PC; Foulkes WD; Giles GG; Hopper JL; Severi G; Eeles R; Easton D; Kote-Jarai Z; Guy M; Rinckleb A; Maier C; Vogel W; Cancel-Tassin G; Egrot C; Cussenot O; Thibodeau SN; McDonnell SK; Schaid DJ; Wiklund F; Grönberg H; Emanuelsson M; Whittemore AS; Oakley-Girvan I; Hsieh CL; Wahlfors T; Tammela T; Schleutker J; Catalona WJ; Zheng SL; Ostrander EA; Isaacs WB; Xu J;
Hum Genet; 2012 Jul; 131(7):1095-103. PubMed ID: 22198737
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
Agalliu I; Kwon EM; Zadory D; McIntosh L; Thompson J; Stanford JL; Ostrander EA
Clin Cancer Res; 2007 Feb; 13(3):839-43. PubMed ID: 17289875
[TBL] [Abstract][Full Text] [Related]
15. Role of HPC2/ELAC2 in hereditary prostate cancer.
Wang L; McDonnell SK; Elkins DA; Slager SL; Christensen E; Marks AF; Cunningham JM; Peterson BJ; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2001 Sep; 61(17):6494-9. PubMed ID: 11522646
[TBL] [Abstract][Full Text] [Related]
16. Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.
Liu W; Sun J; Li G; Zhu Y; Zhang S; Kim ST; Sun J; Wiklund F; Wiley K; Isaacs SD; Stattin P; Xu J; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Zheng SL; Chang BL
Cancer Res; 2009 Mar; 69(6):2176-9. PubMed ID: 19258504
[TBL] [Abstract][Full Text] [Related]
17. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
18. A novel prostate cancer susceptibility locus at 19q13.
Hsu FC; Sun J; Wiklund F; Isaacs SD; Wiley KE; Purcell LD; Gao Z; Stattin P; Zhu Y; Kim ST; Zhang Z; Liu W; Chang BL; Walsh PC; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Xu J; Zheng SL
Cancer Res; 2009 Apr; 69(7):2720-3. PubMed ID: 19318570
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes in the PTEN gene and their association with breast cancer in Pakistan.
Baig RM; Mahjabeen I; Sabir M; Masood N; Hafeez S; Malik FA; Kayani MA
Asian Pac J Cancer Prev; 2011; 12(10):2773-8. PubMed ID: 22320991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]